Low molecular weight heparins. An objective overview (Q35233595)

7 August 2017

1 reference

title

Low molecular weight heparins. An objective overview (English)

1 reference

7 August 2017

D. Hoppensteadt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327312

14 September 2022

J. M. Walenga

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327312

14 September 2022

J. Fareed

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327312

14 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1327312

14 September 2022

publication date

1 September 1992

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

406-422

1 reference

Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review

7 August 2017

cites work

1 reference

12 December 2020

In vivo release of anti-Xa clotting activity by a heparin analogue

1 reference

12 December 2020

Efficacy and safety of two regimens of low molecular weight heparin fragment (Fragmin) in preventing postoperative venous thrombolism

1 reference

12 December 2020

Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine

1 reference

12 December 2020

Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study

1 reference

12 December 2020

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

1 reference

12 December 2020

Prophylaxis of thromboembolism in general surgery: comparison between standard heparin and Fragmin.

1 reference

12 December 2020

Structure of heparins and their fragments

1 reference

12 December 2020

Comparative study on the in vitro and in vivo activities of seven low-molecular-weight heparins

1 reference

12 December 2020

Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.

1 reference

12 December 2020

Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin

1 reference

12 December 2020

Treatment of established venous thromboembolism with enoxaparin: preliminary report.

1 reference

12 December 2020

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

1 reference

12 December 2020

Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis

1 reference

12 December 2020

Anti-Xa active heparin oligosaccharides

1 reference

12 December 2020

Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously

1 reference

12 December 2020

Venous thrombosis after total hip replacement. Combined monitoring as a guide for prophylaxis and treatment.

1 reference

12 December 2020

Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges

1 reference

12 December 2020

Prevention of thromboembolic disease in general surgery with enoxaparin

1 reference

12 December 2020

Thrombin generation and inactivation in the presence of antithrombin III and heparin

1 reference

12 December 2020

Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.

1 reference

12 December 2020

Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement

1 reference

12 December 2020

A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture

1 reference

12 December 2020

Heparin-induced thrombocytopenia, thrombosis, and hemorrhage

1 reference

12 December 2020

Details of glycosaminoglycan conformations and intermolecular interactions

1 reference

12 December 2020

Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin

1 reference

12 December 2020

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis

1 reference

12 December 2020

An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition

1 reference

12 December 2020

An overview of clinical trials of low molecular weight heparin fractions.

1 reference

12 December 2020

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

1 reference

12 December 2020

Sequence variation in heparin octasaccharides with high affinity for antithrombin III.

1 reference

12 December 2020

Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography

1 reference

12 December 2020

The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity

1 reference

12 December 2020

The relative antithrombotic effectiveness of heparin, a low molecular weight heparin, and a pentasaccharide fragment in an animal model

1 reference

12 December 2020

From heparin to heparin fractions and derivatives

1 reference

12 December 2020

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

1 reference

12 December 2020

Electrofocusing of heparin: Presence of 21 monomeric and dimeric molecular species in heparin preparations

1 reference

12 December 2020

A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery

1 reference

12 December 2020

A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study

1 reference

12 December 2020

Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization

1 reference

12 December 2020

Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits

1 reference

12 December 2020

Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fraction

1 reference

12 December 2020

Natural history of postoperative deep-vein thrombosis

1 reference

12 December 2020

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

12 December 2020

Thrombosis prophylaxis with low molecular weight heparin in total hip replacement

1 reference

12 December 2020

A conductimetric method for the determination of sulphate and carboxyl groups in heparin and other mucopolysaccharides

1 reference

12 December 2020

Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.

1 reference

12 December 2020

Validity of the newly established low-molecular-weight heparin standard in cross-referencing low-molecular-weight heparins

1 reference

12 December 2020

Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins

1 reference

12 December 2020

Current status of low molecular weight heparin

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement

1 reference

12 December 2020

Usefulness of fibrinopeptide A generation tests in experimental and clinical studies with low molecular weight heparin fractions

1 reference

12 December 2020

Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively.

1 reference

12 December 2020

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

1 reference

12 December 2020

Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement

1 reference

12 December 2020

Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).

1 reference

12 December 2020

Structure and biological activity of heparin.

1 reference

12 December 2020

The molecular-weight range of mucosal-heparin preparations

1 reference

12 December 2020

A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis

1 reference

12 December 2020

Clinical efficacy of heparin fractions: issues and answers

1 reference

12 December 2020

Laboratory monitoring of the clinical effects of low molecular weight heparins

1 reference

12 December 2020

Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-Novo

1 reference

12 December 2020

Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial

1 reference

12 December 2020

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

12 December 2020

The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate

1 reference

12 December 2020

Venous thromboembolism: epidemiology, diagnosis, prevention

1 reference

12 December 2020

Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement

1 reference

12 December 2020

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

12 December 2020

Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group

1 reference

12 December 2020

Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis

1 reference

12 December 2020

Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects

1 reference

12 December 2020

Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine

1 reference

12 December 2020

A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial

1 reference

12 December 2020

Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin

1 reference

12 December 2020

Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis

1 reference

12 December 2020

Deep venous thrombosis in acute spinal cord injury: a comparison of 125I fibrinogen leg scanning, impedance plethysmography and venography

1 reference

12 December 2020

10.2165/00002512-199202050-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

7 August 2017

1007527181

0 references

Fatcat ID

release_ib2k6nm4xbfvjnmqmvo5tcqkaq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ib2k6nm4xbfvjnmqmvo5tcqkaq

24 November 2022

mapped directly with Wikidata item

1 reference